UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 10-Q

 

(Mark One)

 

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended: February 28, 2015

 

OR

 

[  ] TRANSACTION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ______________ to ______________

 

Commission file number: 333-168413

 

ECOSCIENCES, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Nevada		27-2692640
(State of Other Jurisdiction of		(I.R.S. Employer
Incorporation or Organization)		Identification Number)
420 Jericho Turnpike, Suite 110
Jericho, NY 11753		11753
(Address of Principal Executive Offices)		(Zip Code)

 

(516) 465-3964

(Registrant’s Telephone Number, Including Area Code)

 

With a copy to:

Philip Magri, Esq.

Magri Law, LLC

2642 NE 9th Avenue

Fort Lauderdale, FL 33334

T: (646) 502-5900

F: (646) 826-9200

pmagri@magrilaw.com

www.SEClawyerFL.com

 

N/A

(Former Name, Former Address and Former Fiscal Year, If Changed Since Last Report)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X] No [  ]

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes [  ] No [X]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer,” “non-accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer	[  ]		Accelerated filer	[  ]
Non-accelerated filer	[  ]		Smaller reporting company	[X]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes [  ] No [X]

 

APPLICABLE ONLY TO CORPORATE ISSUERS:

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date. As of April 29, 2015, there were 101,751,500 shares of Common Stock, $0.0001 par value per share, issued and outstanding.

 

 

 

TABLE OF CONTENTS

 

PART I - FINANCIAL INFORMATION
Item 1. Financial Statements (unaudited)		3
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		10
Item 3. Quantitative and Qualitative Disclosures about Market Risk		18
Item 4. Controls and Procedures		18
PART II - OTHER INFORMATION
Item 1. Legal Proceedings		19
Item 1A. Risk Factors		19
Item 2. Unregistered Sale of Equity Securities and Use of Proceeds		19
Item 3. Defaults Upon Senior Securities		19
Item 5. Other Information		19
Item 6. Exhibits		23
SIGNATURES		24

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements (unaudited)

 

Ecosciences, Inc.

Condensed Consolidated Financial Statements

 

Table of Contents

 

		Index
Unaudited Condensed Consolidated Balance Sheets		4
Unaudited Condensed Consolidated Statements of Operations		5
Unaudited Condensed Consolidated Statements of Cash Flows		6
Notes to the Unaudited Condensed Consolidated Financial Statements		7

 

 

Ecosciences, Inc.

Condensed Consolidated Balance Sheets

(Unaudited)

 

		February 28, 2015				May 31, 2014
ASSETS
Current Assets
Cash		$	4,178			$	19,238
Accounts receivable - net			4,126				1,298
Inventory			2,306				2,035
Total Assets		$	10,610			$	22,571
LIABILITIES AND STOCKHOLDERS’ DEFICIT
Current Liabilities
Accounts payable and accrued liabilities		$	157,372			$	39,749
Due to related party			10,600				10,600
Notes payable			204,232				126,732
Convertible notes payable			6,177				6,177
Total Liabilities			378,381				183,258
Stockholders’ Deficit
Preferred Stock 50,000,000 shares authorized, $0.0001 par value;
Series A Redeemable Preferred Stock 1,468,630 shares issued and outstanding (May 31, 2014 – 1,768,630 shares)			147				177
Series B Preferred Stock 200,000 shares issued and outstanding			20				20
Common Stock 500,000,000 shares authorized, $0.0001 par value; 336,751,500 shares issued and outstanding			33,675				33,675
Deficit			(401,613	)			(194,559	)
Total Stockholders’ Deficit			(367,771	)			(160,687	)
Total Liabilities and Stockholders’ Deficit		$	10,610			$	22,571

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 

Ecosciences, Inc.

Condensed Consolidated Statements of Operations

(Unaudited)

 

		Three Months				Three Months				Nine Months				Nine Months
		Ended				Ended				Ended				Ended
		February 28, 2015				February 28, 2014				February 28, 2015				February 28, 2014
Revenue		$	4,805			$	3,562			$	12,999			$	19,065
Cost of sales			(818	)			(244	)			(4,713	)			(3,920	)
Gross Profit			3,987				3,318				8,286				15,145
Expenses
Selling, general and administrative			20,632				14,229				143,800				10,332
Total Expenses			20,632				14,229				143,800				10,332
Net (Loss) Income Before Other Expenses			(16,645	)			(10,911	)			(135,514	)			4,813
Other Expenses
Interest expense			(4,048	)			(728	)			(11,570	)			(1,867	)
Net (Loss) Income		$	(20,693	)		$	(11,639	)		$	(147,084	)		$	2,946
Net (Loss) Income Per Share		$	–			$	–			$	–			$	–
Weighted-average Common Shares Outstanding - Basic and Diluted			336,751,500				250,001,500				336,751,500				250,001,500

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 

Ecosciences, Inc.

Condensed Consolidated Statements of Cash Flows

(Unaudited)

 

		Nine Months Ended February 28, 2015				Nine Months Ended February 28, 2014
Cash Flows from Operating Activities
Net (loss) income		$	(147,084	)		$	2,946
Changes in operating assets and liabilities:
Accounts receivable			(2,828	)			(8,793	)
Prepaid expenses			–				(2,500	)
Inventory			(271	)			(196	)
Accounts payable and accrued liabilities			106,053				9,213
Accrued interest			11,570				1,139
Net Cash (Used in) Provided by Operating Activities			(32,560	)			1,809
Cash Flows from Financing Activities
Proceeds from notes payable			77,500				–
Redemption of Series A redeemable preferred stock			(60,000	)			–
Repayment to related parties			–				(71	)
Net Cash used in Financing Activities			17,500				(71	)
Change in Cash			(15,060	)			1,738
Cash - Beginning of Period			19,238				332
Cash - End of Period		$	4,178			$	2,070
Supplemental Disclosures of Cash Flow Information:
Interest paid		$	–			$	–
Income taxes paid		$	–			$	–

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 

Ecosciences, Inc.

Notes to the Condensed Consolidated Financial Statements

 

1.	Nature of Operations

 

Ecosciences, Inc. (the “Company”) was incorporated in the State of Nevada on May 26, 2010. The Company’s principal business is focused on the development, production and sale of environmentally focused wastewater products. It currently produces organic tablets and powders to be used regularly and in lieu of harmful chemical cleaning products in grease trap and septic tank systems. The Company intends to generate revenue through the sale of tablets and powders to domestic and international customers in the food and sanitation industries as well as residential consumers.

 

The accompanying condensed consolidated financial statements of the Company should be read in conjunction with the financial statements and accompanying notes filed with the U.S. Securities and Exchange Commission in the Company’s Annual Report on Form 10-K for the fiscal year ended May 31, 2014. In the opinion of management, the accompanying condensed consolidated financial statements reflect all adjustments of a recurring nature considered necessary to present fairly the Company’s financial position and the results of its operations and its cash flows for the periods shown.

 

The preparation of condensed consolidated financial statements in accordance with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ materially from those estimates. The results of operations and cash flows for the periods shown are not necessarily indicative of the results to be expected for the full year.

 

2.	Going Concern

 

These condensed consolidated financial statements have been prepared on a going concern basis, which implies that the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The Company has not generated significant revenue since inception and has not generated significant earnings. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability of the Company to obtain necessary equity financing to continue operations, and the attainment of profitable operations. As of February 28, 2015, the Company has accumulated losses of $401,613 and a working capital deficit of $367,771. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. These financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

3.

Inventory

 

Inventory consists of the following:

 

		February 28, 2015				May 31, 2014
Raw Materials		$	294			$	464
Finished Goods			1,509				866
Packaging Supplies			503				705
Total		$	2,306			$	2,035

 

4.	Related Party Transactions

 

At February 28, 2015, and May 31, 2014, the Company was indebted to the President of the Company and a company controlled by the President of the Company for $10,600, for expenses paid on behalf of the Company. The amount is unsecured, non-interest bearing and due on demand.

 

 

Ecosciences, Inc.

Notes to the Condensed Consolidated Financial Statements

 

5.	Notes Payable

 

Notes payable consist of the following:				February 28, 2015				May 31, 2014
	a)	Notes payable that are unsecured, non-guaranteed, non-interest bearing and due on demand.		$	3,732			$	3,732
	b)	Note payable which is unsecured, non-guaranteed, and non-interest bearing. The note is due one year following the borrowing date.			8,000				8,000
	c)	Note payable which is unsecured, non-guaranteed, and bears interest at 10% per annum. The note is due 60 days following demand. At February 28, 2015, and May 31, 2014, the Company owed accrued interest of $3,764 and $2,159, respectively.			20,000				20,000
	d)	Note payable which is unsecured, non-guaranteed, and bears interest at 8% per annum. The note is due one year following the borrowing date. At February 28, 2015, and May 31, 2014, the Company owed accrued interest of $9,736 and $359, respectively.			170,000	*			95,000	*
	e)	Note payable which is unsecured, non-guaranteed, and bears interest at 8% per annum. The note is due one year following the borrowing date. At February 28, 2015, the Company owed accrued interest of $102.			2,500				–
				$	204,232			$	126,732

 

*

On May 9, 2014, the Company entered into a Master Loan Agreement (the “Loan Agreement”), whereby the lender agreed, from time to time, to purchase from the Company one or more Promissory Notes for the account of the Company, provided, however, that the aggregate principal amount of all Promissory Notes then outstanding shall not exceed $500,000 and that no Event of Default has occurred and remains uncured. Amounts borrowed under the Loan Agreement are evidenced by an unsecured, non-recourse Promissory Note, bearing interest at a rate of 8% per annum, maturing on the first anniversary date thereof, and may be prepaid by the Company before the maturity date. Amounts borrowed under the Loan Agreement and repaid or prepaid may not be re-borrowed. The Loan Agreement will automatically terminate and be of no further force and effect upon the earlier to occur of (i) the satisfaction of all indebtedness, including the promissory notes and any additional indebtedness issued thereafter, between the Company and the lender and (ii) written termination notice is delivered by the Company or the lender to the other party.

 

6.	Convertible Notes Payable

 

	a)	On December 22, 2011, the Company entered into two Convertible Promissory Note agreements for an aggregate of $4,000. The Notes bear interest at 10% per annum, and the principal amount and any interest thereon are due 60 days following demand. Pursuant to the agreements, the Notes are convertible into shares of common stock at a conversion price equal to $0.01 per share. At February 28, 2015, and May 31, 2014, the Company owed accrued interest of $1,276 and $959, respectively. At February 28, 2015, and May 31, 2014, the balance owing on the two Notes was $4,000.
	b)	On December 22, 2011, the Company entered into a Convertible Promissory Note agreement for $10,000. The Note bears interest at 10% per annum, and the principal amount and any interest thereon are due 60 days following demand. Pursuant to the agreement, the Note is convertible into shares of common stock at a conversion price equal to $0.01 per share. In addition, as a condition precedent to the right to convert the debt to common stock of the Company, the holder must purchase 3,000,000 shares of common stock at $0.01 per share. No payments of principle or interest have been made during the nine months ended February 28, 2015. At February 28, 2015, and May 31, 2014, the Company owed accrued interest of $219 and $129, respectively. At February 28, 2015, and May 31, 2014, the balance owing on the Note was $1,177.
	c)	On December 28, 2011, the Company entered into a Convertible Promissory Note agreement for $1,000. The Notes bear interest at 10% per annum, and the principal amount and any interest thereon are due 60 days following demand. Pursuant to the agreements, the Notes are convertible into shares of common stock at a conversion price equal to $0.001 per share. At February 28, 2015, and May 31, 2014, the Company owed accrued interest of $317 and $238, respectively. At February 28, 2015, and May 31, 2014, the outstanding balance on the Note was $1,000.

 

 

Ecosciences, Inc.

Notes to the Condensed Consolidated Financial Statements

 

7.	Concentrations

 

The Company’s revenues and receivables were concentrated among three customers as of February 28, 2015, and May 31, 2014:

 

Customer				Revenue for the Year Ended May 31, 2015				Receivables as at May 31, 2015
	1				60	%			65	%
	2				29	%			11	%
	3				11	%			11	%

 

Customer				Revenue for the Nine Months Ended February 28, 2015				Receivables as at February 28, 2015
	1				47	%			47	%
	2				30	%			36	%
	3				12	%			17	%

 

* not greater than 10%

 

8.	Subsequent Events

 

	a)	On April 20, 2015, the Company designated 10,000,000 shares of preferred stock as Series C convertible preferred stock. The holders of the Series C convertible preferred stock may elect to convert their shares at any time and from time to time in their sole discretion. Each share of Series C convertible preferred stock is redeemable at the option of the Company for $0.10 per share and is convertible into 10 shares of common stock of the Company; provided, however, that the holder is prohibited from converting such number of shares of Series C preferred stock that would result in the stockholder beneficially owning more than 4.99% of the common stock of the Company. The holders of the Series C convertible preferred stock also have the right to elect to have any portion of the shares be repurchased by the Company at $0.10 per share. The holders of the Series C preferred stock shall be entitled to a number of votes equal to the number of shares of common stock into which the Series C shares held are convertible.
	b)	On April 20, 2015, the Company entered into a Share Exchange Agreement with a shareholder in which it agreed to exchange 235,000,000 shares of common stock for 4,700,000 shares of Series C convertible preferred stock.
	c)	On March 16, 2015, the Company sold a promissory note for and in the principal amount $15,000. The outstanding principal amount of the note is $15,000, bears interest at 8% per annum and matures on March 16, 2016. The Company may prepay the outstanding principal and accrued interest under the note without penalty thereon.

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

You should read the following discussion together with our condensed consolidated financial statements and the related notes included elsewhere in this report. This discussion contains forward-looking statements, which involve risks and uncertainties. Our actual results may differ materially from those we currently anticipate as a result of many factors, including the factors we describe under “Risk Factors” and elsewhere in this report.

 

Forward Looking Statements

 

Some of the information in this section contains forward-looking statements that involve substantial risks and uncertainties. You can identify these statements by forward-looking words such as “may,” “will,” “expect,” “anticipate,” “believe,” “estimate” and “continue,” or similar words. You should read statements that contain these words carefully because they:

 

	●	discuss our future expectations;
	●	contain projections of our future results of operations or of our financial condition; and
	●	state other “forward-looking” information.

 

We believe it is important to communicate our expectations. However, there may be events in the future that we are not able to accurately predict or over which we have no control. Our actual results and the timing of certain events could differ materially from those anticipated in these forward-looking statements as a result of certain factors, including those set forth under “Risk Factors,” “Business” and elsewhere in this report.

 

Unless stated otherwise, the words “we,” “us,” “our,” the “Company” or “Ecosciences” in this section collectively refer to Ecosciences, Inc. and its wholly-owned subsidiary, Eco-Logical Concepts, Inc.

 

Corporate History

 

We were formerly known as On-Air Impact, Inc., a Nevada corporation (“On-Air Impact”). From the date of its inception on May 26, 2010 until the consummation of the reverse merger described below on May 9, 2014, On-Air Impact had been a “shell company” (as such term is defined in Rule 12b-2 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)).

 

On May 9, 2014, On-Air Impact and its wholly-owned subsidiary, Eco Merger Sub, Inc., a Delaware corporation (“Merger Sub”), consummated a reverse merger (the “Merger”) with Eco-Logical Concepts, Inc., a Delaware corporation (“Eco-Logical”), pursuant to the terms and conditions of that certain Agreement and Plan of Merger, dated May 9, 2014 (the “Merger Agreement”), whereby Merger Sub merged with and into Eco-Logical with Eco-Logical being the surviving corporation and replacing Merger Sub as On-Air Impact’s wholly-owned subsidiary. Since the Merger, the business and operations of Eco-Logical have been business and operations of On-Air Impact.

 

At the closing of the Merger:

 

	●	Every one hundred (100) shares of common stock, par value $0.0001 per share, of Eco-Logical issued and outstanding immediately prior to the closing of the Merger was converted into one (1) share of common stock, par value $0.0001 per share (the “Common Stock”), of On-Air Impact, rounding up to the nearest whole number for resulting fractional shares; and
	●	Each share of Series A Non-Convertible Preferred Stock, par value $0.0001 per share, of Eco-Logical issued and outstanding immediately prior to the closing of the Merger was converted into one share of Series B Non-Convertible Preferred Stock, par value $0.0001 per share (the “Series B Non-Convertible Preferred Stock”), of On-Air Impact.

 

 

In addition, pursuant to the Merger Agreement, on May 9, 2014, Joel Falitz, the President and Chief Executive Officer of Eco-Logical, was appointed to serve as the Chairman of our Board of Directors for a one-year period until the next annual stockholders’ meeting or until his successor is elected and qualified and as the Chief Executive Officer, President, Secretary and Treasurer of the Company.

 

As a result of the Merger, On-Air Impact ceased to be a shell company. The information contained in our “Super Form 8-K” filed on May 15, 2014 constitutes the current “Form 10 information” necessary to satisfy the conditions contained in Rule 144(i)(2) under the Securities Act of 1933, as amended (the “Securities Act”).

 

The Merger was intended to be treated as a tax-free reorganization under Section 368(a) of the Internal Revenue Code of 1986, as amended, and has been treated as a recapitalization of the Company for financial accounting purposes. Even though On-Air Impact was the legal acquirer, Eco-Logical is considered to be the acquirer for accounting purposes, and the Company’s historical financial statements before the Merger will be replaced with the historical financial statements of Eco-Logical before the Merger in this Report and all future filings with the SEC.

 

To better reflect our new operations as a result of the Merger, on June 23, 2014, the Company changed its name from “On-Air Impact” to “Ecosciences, Inc.” On June 23, 2014, we also increased our authorized capital stock from 100 million shares of Common Stock to 500 million shares; and from 10 million shares of “blank check” Preferred Stock, par value $0.0001 per share (“Preferred Stock”) to 50 million shares. We also effectuated a 500-for-1 forward stock split of our outstanding Common Stock on June 23, 2014 (the “Forward Stock Split”).

 

Also, on June 23, 2014, Dorothy Whitehouse and Edward Whitehouse each resigned as a member of our Board of Directors. Their resignations were not due to any disagreement with the Company nor were they related to our operations, policies or practices.

 

On July 21, 2014, the ticker symbol of our Common Stock on the OTCQB was changed from “OAIR” to “ECEZ” to better reflect our new name.

 

Overview

 

Eco-Logical Concepts Inc. (hereinafter referred to as the “Company,” “Eco,” “Eco-Logical,” “our,” we,” “us,” and similar terms) was incorporated in the State of Delaware on November 30, 2011.

 

The following discussion highlights Eco-Logical’s results of operations and the principal factors that have affected our consolidated financial condition as well as our liquidity and capital resources for the periods described, and provides information that management believes is relevant for an assessment and understanding of our consolidated financial condition and results of operations presented herein. The following discussion and analysis is based on Eco-Logical’s audited financial statements contained in this Report, which have been prepared in accordance with generally accepted accounting principles in the United States. You should read the discussion and analysis together with such financial statements and the related notes thereto.

 

As a result of the Merger and the change in our business and operations, a discussion of the past financial results of On-Air Impact, Inc. is not pertinent, and under generally accepted accounting principles in the United States, the historical financial results of Eco-Logical, the accounting acquirer, prior to the Merger are considered the historical financial results of the Company.

 

 

Located in Jericho, New York, Eco-Logical provides bio-remediation services for sewers, sludge ponds, septic tanks, lagoons, farms, car washes, portable sanitation facilities, grease tanks, lakes and ponds. We provide a suite of tablet-based products that can be added to waste systems. The active ingredients in our tablets oxygenate wastewater, remove hydrogen sulfide odors, prevent corrosion in wastewater systems and initiate aerobic biological breakdown of organic sludge including fats, oils and grease. The tablets are non-toxic to the environment, non-caustic and comprised of natural ingredients that do not require any special permitting for use and disposal. The product is simple to use directly by the end consumer.

 

The Company has formulated a business model that management believes can help it grow and achieve economies of scale over time. We have undertaken the necessary due diligence and prepared a business that will enable us to compete in the market for bio-remediation services.

 

The Company is focused on building, acquiring and investing in businesses around ecological and life sciences. From waste water remediation to healthcare and more, Ecosciences is committed to building a better living environment for all people.

 

Growth Strategy of the Company

 

Our mission is to maximize stockholder value through expanding the scope of products offered. We intend to conduct research and development to bring new, improved products to market to ensure we are competitive in our market space. We intend to focus on growing our distribution channels using master-distributor relationships, full-line distributors and other similar sales channels. We intend to build product and brand awareness through a direct retail channel using online marketing and info-commercials, which we believe will provide a feedback benefit for the growth of our other distribution channels as well as to establish opportunities for indirect retail sales channels, such as through chain stores and small retailers.

 

We have been working to set up regional distributors in several different market segments, such as septic systems, grease traps, ponds, agricultural and wastewater. Sales this fiscal year have primarily been to Mexico, and we are currently finalizing more orders locally in New Jersey. All sales were completed in US dollars and have not been subject to any foreign taxes.

 

Critical Accounting Policies, Estimates, and Judgments

 

Our condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. We continually evaluate our estimates and judgments, our commitments to strategic alliance partners and the timing of the achievement of collaboration milestones. We base our estimates and judgments on historical experience and other factors that we believe to be reasonable under the circumstances. Materially different results can occur as circumstances change and additional information becomes known. Besides the estimates identified above that are considered critical, we make many other accounting estimates in preparing our financial statements and related disclosures. All estimates, whether or not deemed critical, affect reported amounts of assets, liabilities, revenues and expenses, as well as disclosures of contingent assets and liabilities. These estimates and judgments are also based on historical experience and other factors that are believed to be reasonable under the circumstances. Materially different results can occur as circumstances change and additional information becomes known, even for estimates and judgments that are not deemed critical.

 

 

Results of Operations

 

Three Months Ended February 28, 2015 Compared to the Three Months Ended February 28, 2014

 

The following table presents Eco-Logical’s results of operations for the periods indicated and as a percentage of total revenue. Historical results are not necessarily indicative of results for future periods.

 

		Three-Month Period Ended February 28,
		2015*								2014*
		$				% of Revenue				$				% of Revenue
Revenue:		$	4,805				-	%		$	3,562				-	%
Cost of sales:			(818	)			(17.04	)%			(244	)			(6.90	)%
Gross profit			3,987				82.98	%			3,318				93.15	%
Operating expenses:
Selling, general and administrative			20,632				429.39	%			14,229				399.47	%
Total Expenses			20,632				429.39	%			14,229				399.47	%
Net loss before other expenses:			(16,645	)			(346.41	)%			10,911				306.32	%
Other expenses:
Interest expense			(4,048	)			(84.25	)%			(728	)			(20.44	)%
Net (loss) income		$	(20,693	)			(430.66	)%			(11,639	)			(326.75	)%

 

*Amounts may not sum due to rounding.

 

The following tables present our revenue and operating expenses for the periods indicated.

 

Revenue

 

		Three-Month Period Ended February 28,
		2015				2014				% Change
Revenue		$	4,805			$	3,562				34.90	%

 

Our Revenue increased 34.90% for the three months ended February 28, 2015 as compared to the three months ended February 28, 2014. The increase is attributed to repeat sales and new accounts.

 

 

Costs and Expenses

 

Cost of Sales

 

		Three-Month Period Ended February 28,
		2015				2014				% Change
Costs of Sales		$	818			$	244				235.25	%

 

Our Costs of Sales increased 235.25% for the three months ended February 28, 2015 as compared to the three months ended February 28, 2014. The increase is due to an increase in sales volume of higher marginal cost goods as well as an increase in overall sales.

 

Operating Expenses

 

		Three-Month Period Ended February 28,
		2015				2014				% Change
Operating Expenses		$	20,632			$	14,229				45.00	%

 

Our Operating Expenses increased 45.00% for three months ended February 28, 2015 as compared to the three months ended February 28, 2014. The increase is attributable to an increase in Professional Fees consisting of legal, accounting and consulting fees as well as administrative costs.

 

Interest Expense

 

		Three-Month Period Ended February 28,
		2015				2014				% Change
Interest Expense		$	4,048			$	728				456.04	%

 

Our Interest Expense increased 456.04% for the three months ended February 28, 2015 as compared to the three months ended February 28, 2014. The increase is attributable to the Company selling $170,000 in notes pursuant to the Loan Agreement with Bacarat from May 9, 2014 through to August 25, 2014.

 

 

Nine Months Ended February 28, 2015 Compared to the Nine Months Ended February 28, 2014

 

The following table presents Eco-Logical’s results of operations for the periods indicated and as a percentage of total revenue. Historical results are not necessarily indicative of results for future periods.

 

		Nine-Month Period Ended February 28,
		2015								2014
		$				% of Revenue				$				% of Revenue
Revenue:		$	12,999				-	%		$	19,065				-	%
Cost of sales:			(4,713	)			(36.26	)%			(3,920	)			(20.56	)%
Gross profit			8,286				63.74	%			15,145				79.44	%
Operating expenses:
Selling, general and administrative			143,800				1,106.24	%			10,332				54.19	%
Total Expenses			143,800				1,106.24	%			10,332				54.19	%
Net loss before other expenses:			(135,514	)			(1,042.50	)%			4,813				25.25	%
Other expenses:
Interest expense			(11,570	)			(89.01	)%			(1,867	)			(9.79	)%
Net (loss) income		$	(147,084	)			(1,131.50	)%			2,946				15.45	%

 

⁽¹⁾ Amounts may not sum due to rounding.

 

The following tables present our revenue and operating expenses for the periods indicated.

 

Revenue

 

		Nine-Month Period Ended February 28,
		2015				2014				% Change
Revenue		$	12,999			$	19,065				(31.82	)%

 

Our Revenue decreased 31.82% for the nine months ended February 28, 2015 as compared to the nine months ended February 28, 2014. The decrease is attributed the exclusion of a large account within the period.

 

Costs and Expenses

 

Cost of Sales

 

		Nine-Month Period Ended February 28,
		2015				2014				% Change
Costs of Sales		$	4,713			$	3,920				20.23	%

 

Our Costs of Sales increased 20.23% for the nine months ended February 28, 2015 as compared to the nine months ended February 28, 2014. The increase in cost with regards to the decrease in sales is attributed to a significant difference in the marginal costs of products sold in the current period.

 

 

Operating Expenses

 

		Nine-Month Period Ended February 28,
		2015				2014				% Change
Operating Expenses		$	143,800			$	10,332				1,291.79	%

 

Our Operating Expenses increased 1,291.79% for the nine months ended February 28, 2015 as compared to the nine months ended February 28, 2014. The increase is attributable to an increase in Professional Fees consisting of legal, accounting and consulting fees. Prior to the reverse merger on May 9, 2014 between the Company’s (then known as On-Air Impact, Inc.) then wholly-owned subsidiary, Eco Merger Sub, Inc., with Eco-Logical Concepts, Inc., the Company had no operations.

 

Interest Expense

 

		Nine-Month Period Ended February 28,
		2015				2014				% Change
Interest Expense		$	11,570			$	2,946				292.74	%

 

Our Interest Expense increased 292.74% for the nine months ended February 28, 2015 as compared to the nine months ended February 28, 2014. The increase is attributable to the Company selling $170,000 in notes pursuant to the Loan Agreement with Bacarat from May 9, 2014 through to August 25, 2014.

 

Financial Condition, Liquidity and Capital Resources

 

At February 28, 2015, we had $4,178 in cash on hand and an accumulated deficit of $401,613; and had $4,805 in revenues for the three month period ended February 28, 2015. In their report for the five months ended May 31, 2014, our auditors have expressed that there is substantial doubt as to our ability to continue as a going concern. We have incurred operating losses since our formation and expect to incur losses and negative operating cash flows for the foreseeable future. We expect to incur substantial losses for the foreseeable future and may never become profitable. We also expect to continue to incur significant operating and capital expenditures for the next several years and anticipate that our expenses will increase substantially in the foreseeable future. We also expect to experience negative cash flow for the foreseeable future as we fund our operating losses and capital expenditures. As a result, we will need to generate significant revenues in order to achieve and maintain profitability. We may not be able to generate these revenues or achieve profitability in the future. Our failure to achieve or maintain profitability could negatively impact the value of our Common Stock.

 

To date, we have financed our operations primarily through the sale of Convertible Promissory Notes to Joel Falitz and other non-affiliated third parties and the issuance and sale of equity securities for cash consideration. As of February 28, 2015, we have financed our operations by the following:

 

●

On May 9, 2014, the Company entered into that certain Master Loan Agreement, dated May 9, 2014 (the “Loan Agreement”), with Bacarat Holdings, Inc., an unaffiliated third party lender (“Bacarat” or the “Lender”). Subject to the terms and conditions set forth in the Loan Agreement, Bacarat agreed, from time to time to purchase from the Company, and the Company agreed to sell and issue to Bacarat, one or more Promissory Notes for the account of the Company, provided, however, that the aggregate principal amount of all Promissory Notes then outstanding shall not exceed the $500,000 and that no Event of Default has occurred and has remained uncured. Amounts borrowed under the Loan Agreement shall be evidenced by an unsecured, non-recourse Promissory Note, bear interest at a rate of 8% per annum, mature on the first anniversary date thereof, and may be prepaid by the Company before the maturity date thereof. Amounts borrowed under the Loan Agreement and repaid or prepaid may not be re-borrowed. The Loan Agreement shall automatically terminate and be of no further force and effect upon the earlier to occur of (i) the satisfaction of all indebtedness, including the promissory notes and any additional indebtedness issued thereafter, between the Company and Bacarat and (ii) written termination notice is delivered by the Company or Bacarat to the other party. There can be no assurances that any additional funds will be available to us under the Loan Agreement since it provides that the Lender may terminate this Agreement at any time.

 

 

As of February 28, 2015, the Company sold the following promissory notes to Bacarat pursuant to the Loan Agreement:

 

Issue Date:		Maturity Date:				Interest Rate:				Principal:
5/9/2014			5/9/2015				8	%		$	50,000
5/19/2014			5/19/2015				8	%			45,000
6/6/2014			6/6/2015				8	%			30,000
8/11/2014			8/11/2015				8	%			25,000
8/18/2014			8/18/2015				8	%			10,000
8/25/2014			8/25/2015				8	%			10,000
TOTAL:			-				-			$	170,000

 

Working Capital

 

The consolidated financial statements filed with this Report have been prepared on a going concern basis, which implies that the Company will continue to realize its assets and discharge its liabilities in the normal course of business. The Company has not generated significant revenue since inception and has not generated significant earnings. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability of the Company to obtain necessary equity financing to continue operations, and the attainment of profitable operations. As of February 28, 2015, the Company has accumulated losses of $401,613 and a working capital deficit of $367,771. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. Our financial statements do not include any adjustments to the recoverability and classification of recorded asset amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Notwithstanding our Loan Agreement with Bacarat that may be terminated upon an uncured Event of Default or by Bacarat at any time, we do not believe our cash resources are sufficient to implement our current business plan, support operations and meet current obligations for the next 12 months. We plan to raise additional capital to finance our operations. There can be no assurance that financing will be available when required in sufficient amounts, on acceptable terms or at all. In the event that the necessary additional financing is not obtained, we may be required to reduce our discretionary overhead costs substantially, including research and development, general and administrative and sales and marketing expenses or otherwise curtail operations.

 

Cash and Cash Equivalents

 

The following table summarizes the sources and uses of cash for the periods stated. The Company held no cash equivalents for any of the periods presented.

 

		Nine Months Ended February 28,
		2015				2014
Cash, beginning of period		$	19,238			$	332
Net cash provided by (used in) operating activities			(32,560	)			1,809
Net cash provided by investing activities			-				-
Net cash provided by financing activities			17,500				(71	)
Cash, end of period		$	4,178			$	2,070

 

 

Off-Balance Sheet Operations

 

The Company does not have any off-balance sheet transactions.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

N/A

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures.

 

In accordance with Exchange Act Rules 13a-15 and 15d-15, our management is required to perform an evaluation under the supervision and with the participation of the Company’s management, including the Company’s principal executive officer and principal financial officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of the end of the period.

 

Based upon that evaluation, our management has concluded that, as of February 28, 2015, our disclosure controls and procedures were not effective.

 

Changes in Internal Control over Financial Reporting

 

No change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) occurred during the fiscal quarter ended February 28, 2015 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings

 

None

 

Item 1A. Risk Factors

 

N/A

 

Item 2. Unregistered Sale of Equity Securities and Use of Proceeds

 

On April 20, 2015, the Company issued to Joel Falitz, the Chief Executive Officer, President, Treasurer, Secretary and Chairman of the Company, an aggregate of 4.7 million (4,700,000) shares of Series C Preferred Stock in exchange for 235 million (235,000,000) shares of Common Stock held by Mr. Falitz. The Company issued the Series C Preferred Stock pursuant to that certain Share Exchange Agreement, dated April 20, 2015, discussed below, under Section 3(a)(9) promulgated under the Securities Act of 1933, as amended, due to the following facts: (i) the Company is the same issuer of the Series C Preferred Stock and Common Stock held by Mr. Falitz; (ii) Mr. Falitz did not part with anything of value in the share exchange besides the 235 million (235,000,000) shares of Common Stock; (iii) the offer was not made to anyone other than Mr. Falitz, a preexisting security holder of the Company; and (iv) the Company did not pay any commission or remuneration for the solicitation of the exchange with Mr. Falitz. The Share Exchange Agreement is filed as an exhibit to this Form 10-Q.

 

Item 3. Defaults Upon Senior Securities

 

N/A

 

Item 5. Other Information

 

Series C Convertible Preferred Stock

 

On April 20, 2015, the Company filed a Certificate of Designation with the Nevada Secretary of State pursuant to which the Company established a new series of Preferred Stock, designated as the Series C Convertible Preferred Stock (the “Series C Preferred Stock”), consisting of ten million (10,000,000) shares of Preferred Stock, par value $0.0001 per share and having the rights, preferences, powers, restrictions and limitations as set forth in the Certificate of Designation, a copy of which is filed as an exhibit to this Form 10-Q and is summarized below:

 

Designations and Amount

 

Ten Million (10,000,000) shares of the Preferred Stock of the Corporation, $0.0001 par value per share, shall constitute a new class of Preferred Stock designated as “Series C Convertible Preferred Stock” (the “Series C Preferred Stock”) with a stated value of $0.001 per share (the “Stated Value”).

 

Conversion

 

Each holder of Series C Preferred Stock (“Holder”) shall have the right, at such Holder’s option, at any time or from time to time from and after the day immediately following the date the Series C Preferred Stock is first issued, to convert each share (“Share”) of Series C Preferred Stock into Ten (10) fully-paid and non-assessable shares of common stock, par value $0.0001 per share, of the Company (the “Common Stock”); provided, however, in connection with any conversion hereunder, each Holder of Series C Preferred Stock may not convert any part of the Series C Preferred Stock if such conversion would cause such Holder or any of its assignees to beneficially own more than 4.99% of the Common Stock of the Company.

 

 

Redemption

 

The Company may, at the Company’s option, at any time or from time to time from and after the day immediately following the date the Series C Preferred Stock is first issued, redeem all or any portion of, on a pro rata basis, the outstanding shares of Series C Preferred Stock for $0.10 per share.

 

The Company shall deliver to the Holders of the outstanding Series C Preferred Stock a written irrevocable redemption notice (the “Redemption Notice”) indicating the amount of shares of Series C Preferred Stock intended to be so redeemed and the date on which such redemption shall be made (the “Redemption Date”). Such Redemption Notice shall be delivered to the Holders of the Series C Preferred Stock at least fifteen (15) business days prior to the Redemption Date.

 

Upon receipt of any Redemption Notice, each Holder of the Series C Preferred Stock shall then have the option (by notifying the Company in writing within ten (10) business days of receipt of the Redemption Notice) to accept the Stated Value in cash or elect to convert not less than all of such Holder’s shares of Series C Preferred Stock pursuant to the terms and conditions set forth herein.

 

Repurchase

 

At any time, and from time to time, on or after the date of issuance, any Holder of Series C Preferred Stock shall have the right to elect to have, out of funds legally available therefor, all or any portion of the shares of Series C Preferred Stock held by such holder be repurchased by the Company (a “Series C Repurchase”) for a price per share equal to $0.10 per share (“Series C Repurchase Price”). Any such Series C Repurchase shall occur not more than sixty (60) days (“Series C Repurchase Date”) following receipt by the Company of a written election notice from any holder of Series C Preferred Stock, stating the aggregate number of shares to be repurchased (the “Series C Election Notice”). In exchange for the surrender to the Company by the respective holders of shares of Series C Preferred Stock of their certificate or certificates representing such Shares, the aggregate Series C Repurchase Price for all shares held by such holder of Series C Preferred Stock shall be payable in cash in immediately available funds to the respective holders of the Series C Preferred Stock on the applicable Series C Repurchase Date, and to no other corporate purpose, except to the extent prohibited by applicable Nevada law.

 

If on any Series C Repurchase Date, the assets of the Company legally available are insufficient to pay the full Series C Repurchase Price for the total number of shares elected to be repurchased, the Company shall (i) take all appropriate action reasonably within its means to maximize the assets legally available for paying the Series C Repurchase Price, (ii) redeem out of all such assets legally available therefor on the applicable Series C Repurchase Date the maximum possible number of Shares that it can redeem on such date, pro rata among the holders of such Shares to be repurchased in proportion to the aggregate number of Shares elected to be repurchased by each such holder on the applicable Series C Repurchase Date and (iii) following the applicable Series C Repurchase Date, at any time and from time to time when additional assets of the Company become legally available to redeem the remaining Shares, the Company shall immediately use such assets to pay the remaining balance of the aggregate applicable Series C Repurchase Price.

 

If on any Series C Repurchase Date, all of the Shares elected to be repurchased pursuant to a Series C Election Notice are not repurchased in full by the Company by paying the entire Series C Repurchase Price, until such Shares are fully repurchased and the aggregate Series C Repurchase Price paid in full, (i) all of the non-repurchased Shares shall remain outstanding and continue to have the rights, preferences and privileges expressed herein, including the accrual and accumulation of dividends thereon.

 

 

Rank

 

Except as specifically provided below, the Series C Preferred Stock shall, with respect to dividend rights, rights on liquidation, winding up and dissolution, rank senior to (i) all classes of Common Stock of the Company and (ii) any class or series of capital stock of the Company hereafter created (unless, with the consent of the Holder(s) of Series C Preferred Stock).

 

Liquidation Preference

 

Except as otherwise provided by the Nevada Revised Statutes and subject to the Certificate of Designation, in the event of any voluntary or involuntary liquidation, dissolution, or winding up of the Company, the Holders of shares of the Series C Preferred Stock then outstanding shall be entitled to be paid, out of the assets of the Company available for distribution to its stockholders, whether from capital, surplus or earnings, an amount equal to the Stated Value.

 

Liquidation

 

Subject to the provisions of the Certificate of Designation, in the event of any voluntary or involuntary liquidation, dissolution, or winding up of the Company, the Holders of shares of the Series C Preferred Stock then outstanding shall be entitled to be paid, out of the assets of the Company available for distribution to its stockholders, whether from capital, surplus or earnings, an amount equal to the Stated Value per share.

 

Dividends/Stock Splits

 

If the Company declares or pays a dividend or distribution on the Common Stock, whether such dividend or distribution is payable in cash, securities or other property, including the purchase or redemption by the Company of shares of Common Stock for cash, securities or property, but excluding any repurchases of Common Stock held by employees or consultants of the Company upon termination of their employment or services pursuant to agreements providing for such repurchase, the Company shall simultaneously declare and pay a dividend on the Series C Preferred Stock on a pro rata basis with the Common Stock determined on an as-converted basis assuming all outstanding shares of Series C Preferred Stock had been converted pursuant to Section 0 as of immediately prior to the record date of the applicable dividend (or if no record date is fixed, the date as of which the record holders of Common Stock entitled to such dividends are to be determined).

 

The number of shares of Common Stock of the Company issuable pursuant to the conversion of outstanding shares of Series C Preferred Stock shall not be adjusted to reflect any forward to reverse stock splits by the Company of its outstanding shares of Common Stock.

 

Voting Rights

 

Each holder of outstanding Shares of Series C Preferred Stock shall be entitled to vote with holders of outstanding shares of Common Stock, voting together as a single class, with respect to any and all matters presented to the stockholders of the Company for their action or consideration (whether at a meeting of stockholders of the Company, by written action of stockholders in lieu of a meeting or otherwise), except as provided by law or by the provisions below. In any such vote, each Share of Series C Preferred Stock shall be entitled to a number of votes equal to the number of shares of Common Stock into which the Share is convertible as of the record date for such vote or written consent or, if there is no specified record date, as of the date of such vote or written consent. Each holder of outstanding Shares of Series C Preferred Stock shall be entitled to notice of all stockholder meetings (or requests for written consent) in accordance with the Company’s bylaws.

 

To the extent that under the Nevada Revised Statutes the vote of the Holders of the Series C Preferred Stock, voting separately as a class or series, as applicable, is required to authorize a given action of the Company, the affirmative vote or consent of the Holders of at least a majority of the shares of the Series C Preferred Stock represented at a duly held meeting at which a quorum is present or by written consent of a majority of the shares of Series C Preferred Stock (except as otherwise may be required under the Nevada Revised Statutes) shall constitute the approval of such action by the class. To the extent that under the Nevada Revised Statutes Holders of the Series C Preferred Stock are entitled to vote on a matter with Holders of Common Stock, voting together as one class, each share of Series C Preferred Stock shall be entitled to ten (10) vote(s).

 

 

Protection Provisions

 

So long as any shares of Series C Preferred Stock are outstanding, the Company shall not, without first obtaining the approval (by vote or written consent, as provided by the Nevada Revised Statutes) of the Holders of at least a majority of the then outstanding shares of Series C Preferred Stock:

 

	●	alter or change the rights, preferences or privileges of the Series C Preferred Stock;
	●	alter or change the rights, preferences or privileges of any capital stock of the Company so as to affect adversely the Series C Preferred Stock;
	●	create any new class or series of capital stock having a preference over the Series C Preferred Stock as to distribution of assets upon liquidation, dissolution or winding up of the Company (as previously defined, “Senior Securities”);
	●	create any new class or series of capital stock ranking pari passu with the Series C Preferred Stock as to distribution of assets upon liquidation, dissolution or winding up of the Company (as previously defined, “Pari Passu Securities”);
	●	increase the authorized number of shares of Series C Preferred Stock;
	●	issue any additional shares of Senior Securities; or
	●	redeem, or declare or pay any cash dividend or distribution on, any Junior Securities.

 

If Holders of at least a majority of the then outstanding shares of Series C Preferred Stock agree to allow the Company to alter or change the rights, preferences or privileges of the shares of Series C Preferred Stock pursuant to subsection (a) above, then the Company shall deliver notice of such approved change to the Holders of the Series C Preferred Stock that did not agree to such alteration or change (the “Dissenting Holders”).

 

Merger, Consolidation, etc.

 

If at any time or from time to time there shall be (i) a merger, or consolidation of the Company with or into another corporation, (ii) the sale of all or substantially all of the Company’s capital stock or assets to any other person, (iii) any other form of business combination or reorganization in which the Company shall not be the continuing or surviving entity of such business combination or reorganization, or (iv) any transaction or Series of transactions by the Company in which in excess of 50 percent of the Company’s voting power is transferred (each, a “Reorganization”), then as a part of such Reorganization, provision shall be made so that the Holders of the Series C Preferred Stock shall thereafter be entitled to receive the same kind and amount of stock or other securities or property (including cash) of the Company, or of the successor corporation resulting from such Reorganization.

 

Share Exchange Agreement

 

On April 20, 2015, the Company entered into a Share Exchange Agreement with Joel Falitz, the Chief Executive Officer, President, Treasurer, Secretary and Chairman of the Company, pursuant to which the Company exchanged Series C Preferred Stock for Common Stock held by Mr. Falitz on a 1-for-50 basis. Pursuant to the Share Exchange Agreement, the Company issued to Mr. Falitz an aggregate of 4.7 million (4,700,000) shares of Series C Preferred Stock in exchange for 235 million (235,000,000) of Common Stock held by Mr. Falitz. The Share Exchange Agreement is filed as an exhibit to this Form 10-Q.

 

 

Promissory Note

 

On March 16, 2015, the Company sold a promissory note for and in the principal amount $15,000. The outstanding principal amount of the note is $15,000, bears interest at 8% per annum and matures on March 16, 2016. The Company may prepay the outstanding principal and accrued interest under the note without penalty thereon.

 

Item 6. Exhibits

 

Index to Exhibits

 

Exhibit:		Description:
3.1*		Certificate of Designation of the Series C Convertible Preferred Stock
10.1*		Share Exchange Agreement, dated April 20, 2015, between Ecosciences, Inc. and Joel Falitz
31.1*		Certification of Principal Executive Officer/Principal Financial and Accounting Officer Pursuant to Exchange Act Rule 13a-14(a)/15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1*		Certification of Principal Executive Officer/Principal Financial and Accounting Officer Pursuant to 18 U.S.C. Section 1350 as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS**		XBRL Instance Document
101.SCH**		XBRL Taxonomy Extension Schema
101.CAL**		XBRL Taxonomy Extension Calculation Linkbase
101.DEF**		XBRL Taxonomy Extension Definition Linkbase
101.LAB**		XBRL Taxonomy Extension Label Linkbase
101.PRE**		XBRL Taxonomy Presentation Linkbase

 

*	Filed herewith.
**	Furnished herewith. Users of this data are advised that, pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Exchange Act of 1934 and otherwise are not subject to liability.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: April 29, 2015	By:	/s/ JOEL FALITZ
	Name:	Joel Falitz
	Title:	President, Chief Executive Officer, Secretary and Treasurer
		(Principal Executive Officer)
		(Principal Financial and Accounting Officer)